The Federal Drug Administration is responsible for the accurate dispensation of medications and treatments, ensuring the safety and security of patients, humans and animals alike. They also oversee the safe distribution of such products to prevent abuse or misuse that can trigger greater harm to the bigger population.
To provide assurance on the effectiveness and safety of low level laser therapy treatments, the FDA cleared the use of such treatment through what they call as Premarket Notification/510(k) process. As a result, devices such as The ML830® Laser are considered as adjunctive devices to help provide pain relief. The FDA clearance was provided based from the clinical results that support the therapeutic claims.
Do you have further inquiries as to the effectiveness and safety of laser treatment therapy? Our expert staff at Mobile Pain Relief Inc can answer questions for you. Just contact us anytime.